The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

4D Pharma Announces Opening of a Study Investigating MRx0518 in Combination with Radiotherapy in Patients with Resectable Pancreatic Cancer
Oncology

4D Pharma Announces Opening of a Study Investigating MRx0518 in Combination with Radiotherapy in Patients with Resectable Pancreatic Cancer

JAN 6, 2020
Psomagen-Macrogen Consortium Acquires All Patents and Data From US Company uBiome
Finance

Psomagen-Macrogen Consortium Acquires All Patents and Data From US Company uBiome

JAN 3, 2020
Carbiotix Signs Research Collaboration Agreement Focused on Neuroinflammation
Pharma & Human Health

Carbiotix Signs Research Collaboration Agreement Focused on Neuroinflammation

DEC 23, 2019
5-minute Microbiome Science Roundup: November 2019
Editor's Choice

5-minute Microbiome Science Roundup: November 2019

DEC 18, 2019
Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test
Gastrointestinal

Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test

DEC 17, 2019
Princeton researchers listen in on the chemical conversation of the human microbiome
Pharma & Human Health

Princeton researchers listen in on the chemical conversation of the human microbiome

DEC 13, 2019
RB and Evolve BioSystems Team Up to Advance Infant Gut Health
Biotics and Supplements

RB and Evolve BioSystems Team Up to Advance Infant Gut Health

DEC 10, 2019
Investigating the human intestinal mucus barrier up-close and personal
Pharma & Human Health

Investigating the human intestinal mucus barrier up-close and personal

DEC 9, 2019
Da Volterra Announces Positive Results of a Phase 1 Drug-Drug Interaction Study
Clinical & Manufacturing

Da Volterra Announces Positive Results of a Phase 1 Drug-Drug Interaction Study

DEC 4, 2019
Caelus Health and Nestlé Health Science sign exclusive global development & option agreement
Biotics and Supplements

Caelus Health and Nestlé Health Science sign exclusive global development & option agreement

NOV 27, 2019
TargEDys, a French microbiome start-up, collects the award for “Best Nutraceutical Product of the Year”
Pharma & Human Health

TargEDys, a French microbiome start-up, collects the award for “Best Nutraceutical Product of the Year”

NOV 25, 2019